Perspective Therapeutics
CATX
30 hedge funds and large institutions have $6.01M invested in Perspective Therapeutics in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.02% more ownership
Funds ownership: 0.76% → 0.78% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
3% less capital invested
Capital invested by funds: $6.18M → $6.01M (-$174K)
3% less funds holding
Funds holding: 31 → 30 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$293K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$72.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.5K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$27.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$145K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$71K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$33.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 5 |
Millennium Management
New York
|
-$19K |
CATX Hedge Fund Activity: Q3 2015 in Review
30 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2015, worth a combined $6.01M — down 2.8% from $6.18M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CATX and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 6 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $293K. The largest seller was AQR Capital Management, cutting an estimated $145K.
- 30 institutional investors held Perspective Therapeutics (CATX) as of Q3 2015, down from 31 in Q2 2015.
- Funds reported $6.01M of Perspective Therapeutics stock for Q3 2015, down 2.8% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q3 2015 and 4 closed out, a net change of -1 holder.
- The largest Perspective Therapeutics buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $293K added.
- The largest Perspective Therapeutics seller in Q3 2015 was AQR Capital Management, an estimated $145K sold.
Based on aggregated 13F filings for Q3 2015.